Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for GlycoMimetics, Inc. (GLYC)

« Back to company index

GLYC Chatter Timeline

Stock Ticker for GLYC

Most Active Tweeters for GLYC

UserTweets
@BuyerHigh 9
@gcassidy718 7
@BlueBioNow 6
@rmacmillan310 4
@MaisaCorp 2

Recent Tweets for GLYC

newsfilterio @newsfilterio
GlycoMimetics to Report Third Quarter Financial Results on November 6, 2020 $GLYC https://t.co/BZUujW0n1g
October 30th 2020, 1:10pm
stock_titan @stock_titan
$GLYC GlycoMimetics to Report Third Quarter Financial Results on November 6, 2020 https://t.co/YSLxPusjEL
October 30th 2020, 9:10am
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed]: Issued Press Release on October 30, 09:00:00: GlycoMimetics to Report Third Quarter Financial… https://t.co/kaXJQ1WIeN
October 30th 2020, 9:10am
gcassidy718 @gcassidy718
$GLYC here we go!! -2.35 % change recently https://t.co/OpTFVD2XBu
October 30th 2020, 7:10am
gcassidy718 @gcassidy718
$GLYC definitely going to finish under $2.68 -8.59 % change recently https://t.co/OpTFVD2XBu
October 29th 2020, 11:10pm
rmacmillan310 @rmacmillan310
$GLYC I’ll probably buy on the dip. Still need to do more research. -8.59 % https://t.co/4HAc7KkPtG
October 29th 2020, 6:10pm
BuyerHigh @BuyerHigh
RT @ChartMill: The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/coby5oRXJT
October 29th 2020, 6:10pm
ChartMill @ChartMill
The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/coby5oRXJT
October 28th 2020, 10:10pm
DayTradeMachine @DayTradeMachine
$GLYC Potential @ Price : 2.99
October 28th 2020, 3:10pm
BuyerHigh @BuyerHigh
RT @MaisaCorp: $GLYC said it is in discussions with the US Food and Drug Administration about how to proceed with development of the drug…
October 27th 2020, 10:10pm
BuyerHigh @BuyerHigh
RT @MaisaCorp: $GLYC presented additional Phase III clinical data at a scientific meeting for its drug candidate rivipansel in the treatmen…
October 27th 2020, 10:10pm
rmacmillan310 @rmacmillan310
$GLYC wow what a great surprise 2.79 % https://t.co/4HAc7KkPtG
October 27th 2020, 7:10pm
equity_newswire @equity_newswire
$GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/C8vDrkqNSu
October 27th 2020, 3:10pm
WhyteStocks @WhyteStocks
News; $GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The $GLYC… https://t.co/rHTBUjhNvK
October 26th 2020, 11:10pm
MaisaCorp @MaisaCorp
$GLYC said it is in discussions with the US Food and Drug Administration about how to proceed with development of… https://t.co/sTh8moD4rM
October 26th 2020, 7:10pm
MaisaCorp @MaisaCorp
$GLYC presented additional Phase III clinical data at a scientific meeting for its drug candidate rivipansel in the… https://t.co/TXN8omWmDr
October 26th 2020, 7:10pm
CloverResearch @CloverResearch
$GLYC always love a post-hoc, let’s search for SOMETHING good, analysis.
October 26th 2020, 4:10pm
BuyerHigh @BuyerHigh
RT @MarketCurrents: $GLYC - GlycoMimetics announces new rivipansel data in sickle cell disease https://t.co/cdMBMnT7hZ
October 26th 2020, 3:10pm
BuyerHigh @BuyerHigh
RT @newsfilterio: GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/2qSVaZJr1x
October 26th 2020, 3:10pm
newsfilterio @newsfilterio
GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/2qSVaZJr1x
October 26th 2020, 12:10pm
HealthcareBeat @HealthcareBeat
GlycoMimetics announces new rivipansel data in sickle cell disease $GLYC https://t.co/sT1FaHeycC
October 26th 2020, 12:10pm
MarketCurrents @MarketCurrents
$GLYC - GlycoMimetics announces new rivipansel data in sickle cell disease https://t.co/cdMBMnT7hZ
October 26th 2020, 12:10pm
Briefingcom @Briefingcom
$GLYC: GlycoMimetics presents new post hoc analyses of the Phase 3 RESET study evaluating the efficacy of rivipanse… https://t.co/90oc7Wdrzc
October 26th 2020, 11:10am
MarcJacksonLA @MarcJacksonLA
$GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/fzUpVYJUfh
October 26th 2020, 10:10am
stock_titan @stock_titan
$GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/nJMeGRoL1J
October 26th 2020, 9:10am
otcdynamics @otcdynamics
$GLYC New Pediatric and Secondary Endpoint Data from Rivipansel Phase 3 RESET Trial Presented at The Annual Scienti… https://t.co/aK25jpZ5uM
October 26th 2020, 9:10am
sbwcws @sbwcws
GlycoMimetics announces new post hoc analyses of rivipansel study $GLYC
October 26th 2020, 9:10am
gcassidy718 @gcassidy718
$GLYC major moves #GLYC -4.49 % change recently https://t.co/OpTFVD2XBu
October 22nd 2020, 5:10pm
rmacmillan310 @rmacmillan310
$GLYC Stock is under performing. . . -4.19 % change recently https://t.co/4HAc7KkPtG
October 22nd 2020, 10:10am
thestockkira @thestockkira
$GLYC buying here to low 3s
October 22nd 2020, 10:10am
BlueBioNow @BlueBioNow
$GLYC major stock movement -4.49 % change recently https://t.co/XgwQoI5WeD
October 22nd 2020, 6:10am
WeekHerald @WeekHerald
Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/yNIzvef967
October 21st 2020, 3:10pm
OlympiaReport @OlympiaReport
Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/q9mNAD6sJ0
October 21st 2020, 3:10pm
AmericanBanking @AmericanBanking
Analysts Expect GlycoMimetics, Inc. $GLYC to Post -$0.33 EPS https://t.co/zHoG9GIHo9 #stocks
October 21st 2020, 3:10pm
thestockkira @thestockkira
$GLYC next support leg is 3.06, I'll buy again for a swing there, made 20%-25% twice on this one
October 21st 2020, 1:10pm
BuyerHigh @BuyerHigh
RT @ChartMill: The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/r0pKZQbvlt
October 21st 2020, 8:10am
ChartMill @ChartMill
The Quick Ratio of $GLYC is much better than the industry average of 5.05. https://t.co/TbukKuMGG0 https://t.co/r0pKZQbvlt
October 21st 2020, 7:10am
gcassidy718 @gcassidy718
$GLYC substantial price changes on this stock -2.09 % https://t.co/OpTFVD2XBu
October 21st 2020, 2:10am
BlueBioNow @BlueBioNow
$GLYC a bit volatility -2.09 % change recently https://t.co/XgwQoI5WeD
October 21st 2020, 1:10am
BlueBioNow @BlueBioNow
$GLYC Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 2.13 % change recently https://t.co/XgwQoI5WeD
October 19th 2020, 7:10pm
SwingTradeBot @SwingTradeBot
20 DMA Support today: $GLYC ... https://t.co/deOpbNqdR6
October 19th 2020, 3:10pm
BlueBioNow @BlueBioNow
$GLYC buyer at $3.69 2.13 % change recently https://t.co/XgwQoI5WeD
October 19th 2020, 11:10am
rmacmillan310 @rmacmillan310
$GLYC headed twds $3.69 . EOQ 2.13 % change recently https://t.co/4HAc7KkPtG
October 19th 2020, 1:10am
BlueBioNow @BlueBioNow
$GLYC substantial stock price changes 2.13 % change recently https://t.co/XgwQoI5WeD
October 18th 2020, 9:10pm
BlueBioNow @BlueBioNow
$GLYC blockbuster 2.13 % change recently https://t.co/XgwQoI5WeD
October 18th 2020, 7:10am
gcassidy718 @gcassidy718
$GLYC buyer at $3.69 2.13 % change recently https://t.co/OpTFVD2XBu
October 18th 2020, 1:10am
BuyerHigh @BuyerHigh
RT @SeekingAlpha: $GLYC - GlycoMimetics' Possible Rivipansel Revival. https://t.co/gaVJmDqndh #stockmarket #investing #finance
October 17th 2020, 2:10pm
BuyerHigh @BuyerHigh
RT @HealthcareBeat: GlycoMimetics' Possible Rivipansel Revival $GLYC https://t.co/PvHG68deph
October 17th 2020, 2:10pm
BuyerHigh @BuyerHigh
RT @Moor_Gamma: Nice timing @CowenResearch ? $GLYC https://t.co/Im1Q4s6Y9b
October 17th 2020, 2:10pm
gcassidy718 @gcassidy718
$GLYC The Broad market is turning Green .. Big Green Reversal coming? 2.13 % change recently https://t.co/OpTFVD2XBu
October 17th 2020, 11:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.